Search Within

Sujata Patil

  1. "Meeting abstract"
Formats
  1. Meeting Abstract (278)
Groups
  1. Biostatistics Service (278)
  2. Epidemiology and Biostatistics (278)
  3. Department of Medicine (212)
  4. Solid Tumor Oncology Division (210)
  5. Survivorship Research (181)
  6. Breast Medicine Service (151)

More Groups

People
  1. Clifford Hudis (90)
  2. Larry Norton (63)
  3. Robert Motzer (51)
  4. Darren Feldman (44)
  5. Edi Brogi (43)
  6. Monica Morrow (38)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (6)
  4. 2020 (14)
  5. 2019 (18)
  6. 2018 (17)

More Years

Publications
  1. Journal of Clinical Oncology (147)
  2. Cancer Research (55)
  3. Annals of Surgical Oncology (29)
  4. Laboratory Investigation (10)
  5. Modern Pathology (9)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (147)
  2. American Association for Cancer Research (56)
  3. Springer (30)
  4. Nature Publishing Group (10)
  5. Nature Research (9)
  6. Oxford University Press (8)

More Publishers

Results (278)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of everolimus and bevacizumab in advanced non-clear cell renal cell cancer
    Meeting Abstract

    Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Patil, S.; Molina, A. M.; Hsieh, J.; Motzer, R. J.; Feldman, D. R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for patients with advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Meeting Abstract

    Lee, C. H.; Hoetker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J.; Motzer, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)
    Meeting Abstract

    Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer
    Meeting Abstract

    Jhaveri, K.; Cadoo, K.; Chandarlapaty, S.; Teplinsky, E.; Speyer, J.; D'Andrea, G.; Patil, S.; Haque, S.; Friedman, K.; Heese, S.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • The extent of lobular carcinoma in situ (LCIS) at surgical excision predicts for the development of subsequent breast cancer
    Meeting Abstract

    Gooch, J. C.; Guerini Rocco, E.; Patil, S.; Koslow, S. B.; De Brot, M.; Park, A. Y.; Boafo, C. A.; Reis, J. S.; King, T. A.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of breast cancer treatment with adjuvant chemotherapy or tamoxifen alone on ovarian reserve
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M.; Moy, F.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save